Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2067553 | 0.79 | CYP1A2 (0.37) | CYP1A2SHBGMEN1ALDH1A1LMNA | |
| SCHEMBL1030996 | 0.79 | CYP1A2 (0.37) | CYP1A2SHBGMEN1ALDH1A1LMNA | |
| SCHEMBL17976970 | 0.77 | CYP1A2 (0.36) | CYP1A2SHBGMEN1ALDH1A1LMNA | |
| SCHEMBL28229024 | 0.77 | CYP1A2 (0.46) | CYP1A2SIGMAR1 | |
| SCHEMBL13640032 | 0.76 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL4977291 | 0.75 | CYP1A2 (0.34) | CYP1A2SHBGMEN1ALDH1A1LMNA | |
| SCHEMBL28893956 | 0.75 | CYP1A2 (0.45) | CYP1A2SIGMAR1 | |
| SCHEMBL20307871 | 0.74 | LMNA (0.32) | MEN1ALDH1A1LMNAALOX12KMT2A | |
| SCHEMBL26257483 | 0.74 | CYP1A2 (0.32) | CYP1A2MEN1ALDH1A1LMNAALOX12 | |
| Oxirane SCHEMBL28775525 | 0.73 | CYP1A2 (0.34) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3898756-B1 | CURABLE POLYMERIC COMPOSITIONS HAVING IMPROVED OXYGEN BARRIER PROPERTIES | GETTERS SPA (IT) | 2022-06-29 | — | — | EP | claimed |
| CN-107921656-A | Processed porous material | 陶氏环球技术有限责任公司 | 2018-04-17 | — | — | CN | claimed |
| CN-103724992-B | Molding compounds, produce the method for product, the application based on ethene and butylene copolymer and by its obtainable product | 朗盛德国有限责任公司 | 2017-11-24 | — | — | CN | claimed |
| EP-3180381-B1 | CURABLE ADHESIVE COMPOSITIONS FOR FLEXIBLE SUBSTRATES | GETTERS SPA (IT) | 2017-11-22 | — | — | EP | claimed |
| CN-102585490-B | The flame-retardant polyamide composition filled with ground glass | 朗盛德国有限责任公司 | 2017-07-21 | — | — | CN | claimed |
| CN-102952395-B | There is the thermoplastic molding compoistions of the hydrolysis toleration of increase | 朗盛德国有限责任公司 | 2016-07-06 | — | — | CN | claimed |
| CN-103221216-B | Multi-layer thermoplastic semi-finished fiber matrix product | LANXESS DEUTSCHLAND GMBH (DE) | 2015-10-14 | — | — | CN | claimed |
| US-7361713-B2 | Blush resistant adhesives used in bottle labeling | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2008-04-22 | — | — | US | claimed |
| CN-1814685-A | Blush resistant adhesives used in bottle labeling | AIR PRODUCTS POLYMERS LP (US) | 2006-08-09 | — | — | CN | claimed |
| US-20060135696-A1 | Blush resistant adhesives used in bottle labeling | ARKEMA FRANCE (FR) | 2006-06-22 | — | — | US | claimed |
| EP-1672045-A2 | Blush resistant adhesives used in bottle labeling | AIR PRODUCTS POLYMERS, L.P. (US) | 2006-06-21 | — | — | EP | claimed |
| CN-119137180-A | Latent amine compositions for flame retardant epoxy systems | 赢创运营有限公司 | 2024-12-13 | — | — | CN | disclosed |
| EP-3622007-B1 | POLYAMIDE TERPOLYMERS FOR MANUFACTURE OF TRANSPARENT ARTICLES | ADVANSIX RESINS & CHEMICALS LLC (US) | 2024-10-23 | — | — | EP | disclosed |
| US-11629166-B2 | Compound for treating clostridium difficile | ASTON UNIVERSITY (GB) | 2023-04-18 | — | — | US | disclosed |
| US-20200131223-A1 | COMPOUND FOR TREATING CLOSTRIDIUM DIFFICILE | INSIGHT HEALTH LIMITED | 2020-04-30 | — | — | US | disclosed |
| EP-0542766-B1 | PROCESS FOR PRODUCING CLOSURES OF PACKAGING CONTAINERS | BASF LACKE & FARBEN (DE) | 1996-01-24 | — | — | EP | disclosed |
| EP-0542766-A1 | PROCESS FOR PRODUCING CLOSURES OF PACKAGING CONTAINERS. | BASF LACKE & FARBEN (DE) | 1993-05-26 | — | — | EP | disclosed |
| WO-1992002592-A1 | PROCESS FOR PRODUCING CLOSURES OF PACKAGING CONTAINERS | BASF LACKE + FARBEN AKTIENGESELLSCHAFT (DE) | 1992-02-20 | — | — | WO | disclosed |
| US-4581209-A | N-aminoalkyl alkylpiperazine promoted acid gas scrubbing process | EXXON RESEARCH AND ENGINEERING CO. (US) | 1986-04-08 | — | — | US | disclosed |
| US-4046725-A | NON-THROMBOGENIC | RHONE-POULENC INDUSTRIES (FR) | 1977-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11629166-B2 | Compound for treating clostridium difficile | DSTN, DAD1, DDOST | CYP1A2 1116/4885SHBG 4087/4885MEN1 2594/4885 |
| US-20200131223-A1 | COMPOUND FOR TREATING CLOSTRIDIUM DIFFICILE | DSTN, DAD1, DDOST | CYP1A2 1116/4885SHBG 4087/4885MEN1 2594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.